Ajay Verma
Chief Executive Officer bei Sahayata Microfinance Pvt Ltd.
Profil
Ajay Verma is currently the Chief Executive Officer & Managing Director at Sahayata Microfinance Pvt Ltd.
Previously, he worked as the Executive VP-Research & Experimental Medicine at Codiak BioSciences, Inc. and as the Executive VP, Head-Research & Development at Yumanity Therapeutics, Inc. from 2021 to 2022.
Dr. Verma holds a doctorate degree from The Johns Hopkins University, an undergraduate degree from the University of Rajasthan, and an MBA from Jai Narain Vyas University.
Aktive Positionen von Ajay Verma
| Unternehmen | Position | Beginn |
|---|---|---|
Sahayata Microfinance Pvt Ltd.
 Sahayata Microfinance Pvt Ltd. Finance/Rental/LeasingFinance Sahayata Microfinance Pvt Ltd. engages in arranging loans. The company was founded in September 2006 and is headquartered in Udaipur, India. | Chief Executive Officer | 25.02.2010 |
Ehemalige bekannte Positionen von Ajay Verma
| Unternehmen | Position | Ende |
|---|---|---|
| YUMANITY THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01.01.2022 |
| CODIAK BIOSCIENCES | Corporate Officer/Principal | 05.03.2021 |
Ausbildung von Ajay Verma
| The Johns Hopkins University | Doctorate Degree |
| University of Rajasthan | Undergraduate Degree |
| Jai Narain Vyas University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Sahayata Microfinance Pvt Ltd.
Sahayata Microfinance Pvt Ltd. Finance/Rental/LeasingFinance Sahayata Microfinance Pvt Ltd. engages in arranging loans. The company was founded in September 2006 and is headquartered in Udaipur, India. | Finance |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA. | Health Technology |
